USP24 suppresses T cell anti-tumor activity by enhancing the stability of the PD-1 protein

被引：0
|
作者：
Hsieh, Hung-Chia
Hung, Jan-Jong
Wang, Yi-Ching
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB445
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Enhancement of anti-tumor effects of PD-1 inhibitors by modulation of lipid metabolism in tumor microenvironment
    Katoh, Yuki
    Yaguchi, Tomonori
    Iwata, Takashi
    Kawana, Kei
    Kawakami, Yutaka
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 148 : 1 - 2
  • [42] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [43] Dual inhibition of PD-1 and LAG-3: uncovering mechanisms to reverse T cell exhaustion and enhance anti-tumor immunity
    Zhou, Xiaoxue
    Zhou, Fangfang
    Zhang, Long
    SCIENCE BULLETIN, 2025, 70 (05) : 624 - 626
  • [44] Enhancing the Efficacy of Anti-tumor Immunotherapy by Targeting T cell Metabolism
    Xin Pei Ji
    Qiu Yan Liu
    Journal of Nutritional Oncology, 2019, 4 (02) : 67 - 73
  • [45] Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
    Okada, Masahiro
    Chikuma, Shunsuke
    Kondo, Taisuke
    Hibino, Sana
    Machiyama, Hiroaki
    Yokosuka, Tadashi
    Nakano, Miyako
    Yoshimura, Akihiko
    CELL REPORTS, 2017, 20 (05): : 1017 - 1028
  • [46] PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cells
    Liu, Guodi
    Zhang, Qian
    Li, Dehua
    Zhang, Linsong
    Gu, Zhangjie
    Liu, Jibin
    Liu, Guoping
    Yang, Mu
    Gu, Jinwei
    Cui, Xingbing
    Pan, Yingjiao
    Tian, Xiaoli
    HUMAN IMMUNOLOGY, 2021, 82 (02) : 130 - 138
  • [47] Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing anti-tumor T cell immunity.
    Pyo, Kyoung-Ho
    Lee, Wongeun
    Lee, Hee Kyu
    Kim, Dong Kwon
    Jo, Ha Ni
    Synn, Chun-Bong
    Kim, Jae Hwan
    Byeon, Yeongseon
    Kim, Young Seob
    Ahn, Beung-Chul
    Hong, Min Hee
    Lim, Sun Min
    Cho, Byoung Chul
    Kim, Hye Ryun
    CANCER RESEARCH, 2021, 81 (13)
  • [48] PD-1 Tumor Suppressor Signaling in T Cell Lymphomas
    Wartewig, Tim
    Ruland, Juergen
    TRENDS IN IMMUNOLOGY, 2019, 40 (05) : 403 - 414
  • [49] Combining CD27 costimulation and PD-1 blockade into a bispecific antibody improves T cell activation and anti-tumor activity over combination of individual antibodies
    Vitale, Laura
    Thomas, Lawrence
    O'Neill, Thomas
    Widger, Jenifer
    Mills-Chen, Laura
    Crocker, Andrea
    Patterson, Colleen
    Wasiuk, Anna
    Forsberg, Eric
    Boyer, James
    Sisson, Crystal
    Weidlick, Jeffrey
    Renn-Bingham, Shannon
    Papayannopoulos, Ioannis
    Hammond, Russ
    Goldstein, Joel
    Marsh, Henry, Jr.
    He, Li-Zhen
    Yellin, Michael
    Keler, Tibor
    Keler, Tibor
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [50] Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy
    Jiang, Mengshi
    Li, Wei
    Zhu, Chunqi
    Li, Xiang
    Zhang, Junlei
    Luo, Zhenyu
    Qin, Bing
    Du, Yongzhong
    Luo, Lihua
    You, Jian
    Journal of Controlled Release, 2021, 329 : 1023 - 1036
12345